Real-time enrollment status for this philadelphia-negative all clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:57 PM UTC
| NCT Number | NCT06287528 |
| Recruiting Status | Recruiting |
| Condition | Philadelphia-Negative ALL |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | February 10, 2026 (Feb 10, 2026) |
As of August 28, 2026: Clinical trial NCT06287528 is currently recruiting participants. This phase1 study for philadelphia-negative all is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06287528 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06287528 was last updated Feb 10, 2026 (February 10, 2026). HelloStudys verifies this status automatically.